Home › Companies › MYRIAD GENETICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and MYRIAD GENETICS INC.’s Form 8-K, filed June 6, 2024 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of June 6, 2024: 4 items on MYRIAD GENETICS INC.’s Form 8-K, filed June 6, 2024: 2 approved · 2 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore MYRIAD GENETICS INC. in the interactive database Compare manager voting policies
These tallies are MYRIAD GENETICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: S. Louise Phanstiel | 72,176,819 | 6,303,679 | 44,684 | -- | 5,899,075 | 92% | Not verified | — |
| Elect Director: Daniel M. Skovronsky | 77,928,386 | 557,211 | 39,585 | -- | 5,899,075 | 99.2% | Not verified | — |
| 2. Ratification of the Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024 | 81,454,833 | 2,917,829 | 51,595 | -- | -- | 97% | Approved | — |
| 3. Approval, on an Advisory Basis, of the Compensation of Our Named Executive Officers, as Disclosed in the Proxy Statement | 74,410,679 | 4,060,490 | 54,013 | -- | 5,899,075 | 95% | Approved | — |
This meeting is also recorded here as June 7, 2024; both records come from the same filing, so the date should be checked against it.
Source: MYRIAD GENETICS INC., Form 8-K, filed with the SEC on June 6, 2024 — read the filing on EDGAR.
Each item below shows how the 264 asset managers that disclosed a MYRIAD GENETICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: Election of two Class I Directors to serve until the 2027 Annual Meeting of Stockholders: Daniel M. Skovronsky, M.D., Ph.D.
MYRIAD GENETICS INC.’s own tally for this item (“Elect Director: Daniel M. Skovronsky”): 77,928,386 for, 557,211 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 79 asset managers below reported 40,028,084 for, 4,846 against, 6,470 abstained, 68,732 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,825,017 | 0 | 0 | 0 | For |
| BlackRock | 9,988,927 | 0 | 0 | 0 | For |
| State Street | 3,420,534 | 4,846 | 0 | 0 | For |
| Dimensional | 2,303,328 | 0 | 0 | 0 | For |
| Fidelity | 1,944,192 | 0 | 0 | 0 | For |
| Artisan | 1,612,034 | 0 | 0 | 0 | For |
| TIAA | 1,456,074 | 0 | 0 | 0 | For |
| Charles Schwab | 946,373 | 0 | 0 | 0 | For |
| Invesco | 531,926 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 346,931 | 0 | 0 | 0 | For |
| Goldman Sachs | 275,208 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 240,103 | 0 | 0 | 0 | For |
| Equitable | 231,983 | 0 | 0 | 0 | For |
| Jackson National | 212,044 | 0 | 0 | 0 | For |
| Global X | 181,189 | 0 | 0 | 0 | For |
| Allspring | 144,958 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 143,912 | 0 | 0 | 0 | For |
| Prudential/PGIM | 134,608 | 0 | 0 | 0 | For |
| BNY Mellon | 129,684 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,189 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 119,476 | 0 | 0 | 0 | For |
| Lincoln Financial | 116,399 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 116,379 | 0 | 0 | 0 | For |
| Thrivent | 114,077 | 0 | 0 | 0 | For |
| Empower | 31,041 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 4 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: Election of two Class I Directors to serve until the 2027 Annual Meeting of Stockholders: S. Louise Phanstiel
MYRIAD GENETICS INC.’s own tally for this item (“Elect Director: S. Louise Phanstiel”): 72,176,819 for, 6,303,679 against, per its Form 8-K filed June 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 79 asset managers below reported 39,334,948 for, 697,982 against, 6,470 abstained, 68,732 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,825,017 | 0 | 0 | 0 | For |
| BlackRock | 9,988,927 | 0 | 0 | 0 | For |
| State Street | 3,411,437 | 13,943 | 0 | 0 | For |
| Dimensional | 2,303,328 | 0 | 0 | 0 | For |
| Fidelity | 1,944,192 | 0 | 0 | 0 | For |
| Artisan | 1,612,034 | 0 | 0 | 0 | For |
| TIAA | 1,456,074 | 0 | 0 | 0 | For |
| Charles Schwab | 946,373 | 0 | 0 | 0 | For |
| Invesco | 0 | 531,926 | 0 | 0 | Against |
| OLD WESTBURY FUNDS INC | 346,931 | 0 | 0 | 0 | For |
| Goldman Sachs | 275,208 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 240,103 | 0 | 0 | 0 | For |
| Equitable | 127,633 | 104,350 | 0 | 0 | Mixed |
| Jackson National | 212,044 | 0 | 0 | 0 | For |
| Global X | 181,189 | 0 | 0 | 0 | For |
| Allspring | 144,958 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 143,912 | 0 | 0 | 0 | For |
| Prudential/PGIM | 134,608 | 0 | 0 | 0 | For |
| BNY Mellon | 129,684 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,189 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 119,476 | 0 | 0 | 0 | For |
| Lincoln Financial | 116,399 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 116,379 | 0 | 0 | 0 | For |
| Thrivent | 114,077 | 0 | 0 | 0 | For |
| Empower | 31,041 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 8 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.
MYRIAD GENETICS INC.’s own tally for this item (“3. Approval, on an Advisory Basis, of the Compensation of Our Named Executive Officers, as Disclosed in the Proxy Statement”): 74,410,679 for, 4,060,490 against — passed, per its Form 8-K filed June 6, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: Approval, on an Advisory Basis, of the Compensation of Our Named Executive Officers, as Disclosed in the Proxy Statement”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,825,017 | 0 | 0 | 0 | For |
| BlackRock | 9,988,927 | 0 | 0 | 0 | For |
| Artisan | 3,668,676 | 0 | 0 | 0 | For |
| State Street | 3,425,380 | 0 | 0 | 0 | For |
| Dimensional | 2,303,328 | 0 | 0 | 0 | For |
| Fidelity | 1,944,192 | 0 | 0 | 0 | For |
| TIAA | 1,456,074 | 0 | 0 | 0 | For |
| Charles Schwab | 946,373 | 0 | 0 | 0 | For |
| Invesco | 0 | 531,926 | 0 | 0 | Against |
| OLD WESTBURY FUNDS INC | 346,931 | 0 | 0 | 0 | For |
| Goldman Sachs | 275,208 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 240,103 | 0 | 0 | 0 | For |
| Equitable | 231,983 | 0 | 0 | 0 | For |
| Jackson National | 212,044 | 0 | 0 | 0 | For |
| Global X | 181,189 | 0 | 0 | 0 | For |
| Allspring | 144,958 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 143,912 | 0 | 0 | 0 | For |
| Prudential/PGIM | 134,608 | 0 | 0 | 0 | For |
| BNY Mellon | 129,684 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,189 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 0 | 119,476 | 0 | 0 | Against |
| Lincoln Financial | 116,399 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 116,379 | 0 | 0 | 0 | For |
| Thrivent | 114,077 | 0 | 0 | 0 | For |
| Empower | 31,041 | 0 | 0 | 0 | For |
Fund voting reports, all 78 managers: 41,424,707 for, 664,682 against, 6,470 abstained, 68,732 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Camber Capital Management LP | 7,485,000 | 0 | 0 | 0 | For |
| Wellington | 6,162,660 | 0 | 0 | 0 | For |
| State Street | 5,145,596 | 0 | 0 | 0 | For |
| EARNEST PARTNERS LLC | 3,735,094 | 0 | 0 | 0 | For |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 3,570,267 | 0 | 0 | 0 | For |
| BlackRock | 2,613,905 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,015,700 | 0 | 0 | 0 | For |
| DISCIPLINED GROWTH INVESTORS INC /MN | 0 | 1,724,237 | 0 | 0 | Against |
| Nuveen | 1,492,806 | 0 | 0 | 0 | For |
| Charles Schwab | 987,320 | 0 | 0 | 0 | For |
| DE Shaw | 940,276 | 0 | 0 | 0 | For |
| Northern Trust | 912,995 | 54 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 672,063 | 0 | 0 | 0 | For |
| Citadel | 660,289 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 595,244 | 0 | 0 | 0 | For |
| Invesco | 0 | 564,575 | 0 | 0 | Against |
| PRINCIPAL GLOBAL INVESTORS | 465,509 | 0 | 0 | 0 | For |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 446,061 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 0 | 368,877 | 0 | 0 | Against |
| Goldman Sachs | 356,975 | 0 | 0 | 0 | For |
| BESSEMER INVESTMENT MANAGEMENT LLC | 346,931 | 0 | 0 | 0 | For |
| Dimensional | 295,376 | 0 | 0 | 0 | For |
| Natixis | 236,577 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 231,216 | 0 | 0 | 0 | For |
| BNY Mellon | 167,287 | 0 | 0 | 0 | For |
Institutional-manager reports, all 209 managers: 42,644,263 for, 3,364,966 against, 12,507 abstained, 193 not voted. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
MYRIAD GENETICS INC.’s own tally for this item (“2. Ratification of the Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024”): 81,454,833 for, 2,917,829 against — passed, per its Form 8-K filed June 6, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, was approved by stockholders.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 79 asset managers below reported 39,982,070 for, 50,860 against, 6,470 abstained, 68,732 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,825,017 | 0 | 0 | 0 | For |
| BlackRock | 9,988,927 | 0 | 0 | 0 | For |
| State Street | 3,420,757 | 4,623 | 0 | 0 | For |
| Dimensional | 2,303,328 | 0 | 0 | 0 | For |
| Fidelity | 1,944,192 | 0 | 0 | 0 | For |
| Artisan | 1,612,034 | 0 | 0 | 0 | For |
| TIAA | 1,456,074 | 0 | 0 | 0 | For |
| Charles Schwab | 946,373 | 0 | 0 | 0 | For |
| Invesco | 531,926 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 346,931 | 0 | 0 | 0 | For |
| Goldman Sachs | 275,208 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 240,103 | 0 | 0 | 0 | For |
| Equitable | 231,983 | 0 | 0 | 0 | For |
| Jackson National | 212,044 | 0 | 0 | 0 | For |
| Global X | 181,189 | 0 | 0 | 0 | For |
| Allspring | 144,958 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 143,912 | 0 | 0 | 0 | For |
| Prudential/PGIM | 134,608 | 0 | 0 | 0 | For |
| BNY Mellon | 129,684 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,189 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 119,476 | 0 | 0 | 0 | For |
| Lincoln Financial | 116,399 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 116,379 | 0 | 0 | 0 | For |
| Thrivent | 114,077 | 0 | 0 | 0 | For |
| Empower | 31,041 | 0 | 0 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 90,500,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 15.28% |
| 2 | BlackRock | 11.04% |
| 3 | Artisan | 4.05% |
| 4 | State Street | 3.78% |
| 5 | Dimensional | 2.55% |
| 6 | Fidelity | 2.15% |
| 7 | TIAA | 1.61% |
| 8 | Charles Schwab | 1.05% |
| 9 | Invesco | 0.59% |
| 10 | OLD WESTBURY FUNDS INC | 0.38% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Camber Capital Management LP | 8.27% |
| 2 | Wellington | 6.81% |
| 3 | State Street | 5.69% |
| 4 | EARNEST PARTNERS LLC | 4.13% |
| 5 | GLENVIEW CAPITAL MANAGEMENT, LLC | 3.95% |
| 6 | BlackRock | 2.89% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.23% |
| 8 | DISCIPLINED GROWTH INVESTORS INC /MN | 1.91% |
| 9 | Nuveen | 1.65% |
| 10 | Charles Schwab | 1.09% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 16.44% | 13F |
| Vanguard Group | 8.71% | 13F |
| State Street | 5.97% | 13F |
| Millennium Management | 4.74% | 13F |
| Morgan Stanley | 4.00% | 13F |
| Dimensional Fund Advisors | 2.99% | 13F |
| Goldman Sachs | 2.38% | 13F |
| Geode Capital | 2.23% | 13F |
| Nuveen | 1.58% | 13F |
Percentages above are of 90,500,000 shares outstanding, as reported by MYRIAD GENETICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MYRIAD GENETICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At MYRIAD GENETICS INC.'s shareholder meeting held June 6, 2024, in the 2023-2024 proxy season, 264 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 1,367 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers, as… — MYRIAD GENETICS INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: MYRIAD GENETICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2024.
MYRIAD GENETICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.